Plain-English translation of NCT03327779 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Hemophilia A research guide โThe World Bleeding Disorders Registry is a long-term study collecting health information from people diagnosed with hemophilia A, hemophilia B, or von Willebrand disease at participating treatment centers around the world. By gathering data from thousands of patients across more than 50 countries, researchers hope to better understand how these conditions affect people's lives and what treatments work best in real-world settings.
Right now, doctors and researchers don't have enough information about how bleeding disorders affect patients globally and how different treatment approaches work in different parts of the world. This registry aims to fill that gap by collecting real-world experiences and outcomes from diverse patient populations, which can help improve care for everyone with these conditions.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this registry, your hemophilia treatment center will securely share your medical information (such as your diagnosis, treatments, and health outcomes) into a global database. There are no additional visits or procedures required beyond your regular care โ you simply allow your doctors to contribute your de-identified health data to help researchers worldwide better understand bleeding disorders.
AI-generated summary from trial data ยท Jun 3, 2026 ยท Not medical advice
Canada
Enrollment target
~20,000 participants
Started
January 2018
Primary completion
January 2028
Last updated on clinicaltrials.gov in August 2023.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Donna Coffin, M.Sc.
World Federation of Hemophilia
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.